Company Name
LAMINAR PHARMACEUTICALS, SA
Activity
We are a pioneering biopharmaceutical company, focused on the discovery, rational design and initial clinical development of drugs. These compounds are all based on a novel therapeutic approach: Membrane Lipid Therapy (MLT), or melitherapy for short, which targets membrane lipids, instead of acting directly on proteins or DNA as most medicines do.
CIF
A57451171
Sector
BioPharmaceuticals
Address
CARRETERA VALLDEMOSSA km 7,4 -PARC BIT - EDIFICIO NAORTE, BLOQUE A, 1ª planta. Puerta 3 - Palma de Mallorca
EPM Joining Date
04/06/2020
Creation Date
17/10/2006
Founders Pablo Escribá / Vicenç Tur
Auditor
KPMG
Investors email contact
info@laminarpharma.com / inversores@laminarpharma.com
Company profile
On the Road to BME Growth
- 01/05/2007 - Board of Directors
- 04/08/2020 - Transformation in PLC
Relevant data
| (thousand of Euros) | 2023 | 2024 | 2025* | 2026* |
|---|---|---|---|---|
| Net worth | 31.697 | 38.647,65 | 49.976,47 | 81.539,74 |
| Net business turnover | 7.223,12 | 10.387,53 | 11.687,96 | 30.025 |
| Financial debt | - | - | - | - |
| Ebitda | -1.182,12 | 345,54 | 3.535,66 | 25.622,34 |
| Net Profit | -1.868,62 | -418,49 | 2.574,89 | 21.237,67 |
| Average number of employees | 24 | 27 | 27 | 30 |
| * Proyection | ||||
Investment Rounds
| Date | Status | Amount | Minimum Ticket |
|---|---|---|---|
| 12-04-2021 | Closed | 1.605.804,05 | 1000,00 |
| 03-12-2021 | Closed | 1.766.450,78 | 1000,00 |
| 16-05-2022 | Closed | 1.341.618,31 | 1000,00 |
| 26-09-2022 | Closed | 3.522.124,4 | 1000,00 |
| 10-03-2023 | Closed | 3.164.434,77 | 1000,00 |
| 15-11-2023 | Closed | 9.026.000,35 | 1000,00 |
| 15-03-2024 | Closed | 3.023.029,5 | 3000,00 |
| 03-12-2024 | Closed | 5.913.625,3 | 3000,00 |
| 01-06-2025 | Open | 20.000.000 | 3000,00 |
Business Model
License and supply to large pharmaceutical companies worldwide, under a B2B exploitation model.
Competitive advantage
Development of oncological drugs and other 'first in class' products based on the technology called Membrane Lipid Therapy (MLT), which is strongly patented worldwide, a completely differential and innovative therapeutic platform. MLT uses high-safety therapeutic lipid molecules to improve the quality of life of people affected by serious incurable diseases.
Scalability
Medical innovation at the service of humanity
